Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00117111255692913 -0.0010409889394925 -0.0010409889394925 -0.0010409889394925
Stock impact report

Brainstorm Health: Sage Postpartum Drug, Gilead Price Hikes, Peloton Suit [Fortune]

Sage Therapeutics, Inc. (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
Company Research Source: Fortune
Brainstorm Health: Sage Postpartum Drug, Gilead Price Hikes, Peloton Suit By Sy Mukherjee 6:49 PM EDT Hello and happy hump day, readers. Sage Therapeutics notched a pioneering victory on Tuesday when the Food and Drug Administration (FDA) approved its postpartum depression drug Zulresso The agency’s approval of Zulresso, the brand name for a therapy called brexanolone, was widely expected In fact, as the FDA explains, the drug’s marketing comes with a number of restrictions. “Because of concerns about serious risks, including excessive sedation or sudden loss of consciousness during administration, Zulresso has been approved with a Risk Evaluation and Mitigation Strategy (REMS) and is only available to patients through a restricted distribution program at certified health care facilities where the health care provider can carefully monitor the patient,” wrote the FDA’s Tiffany Farchione in a statement. Zulresso must be administered via IV infusion by a doctor at a health care facility Show less Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SAGE alerts

from News Quantified
Opt-in for
SAGE alerts

from News Quantified